303 related articles for article (PubMed ID: 31657827)
61. Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.
Kortsmit K; Williams L; Pazol K; Smith RA; Whiteman M; Barfield W; Koumans E; Kourtis A; Harrison L; Bauman B; Warner L
JAMA Pediatr; 2019 Jul; 173(7):663-670. PubMed ID: 31107513
[TBL] [Abstract][Full Text] [Related]
62. Improving LARC Access for Urban Adolescents and Young Adults in the Pediatric Primary Care Setting.
Onyewuchi UF; Tomaszewski K; Upadhya KK; Gupta PS; Whaley N; Burke AE; Trent ME
Clin Pediatr (Phila); 2019 Jan; 58(1):24-33. PubMed ID: 30318927
[TBL] [Abstract][Full Text] [Related]
63. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
Broecker J; Jurich J; Fuchs R
Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
[TBL] [Abstract][Full Text] [Related]
64. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
65. Long-acting reversible contraception: Findings from the Understanding Fertility Management in Contemporary Australia survey.
Holton S; Rowe H; Kirkman M; Jordan L; McNamee K; Bayly C; McBain J; Sinnott V; Fisher J
Eur J Contracept Reprod Health Care; 2016; 21(2):116-31. PubMed ID: 26043118
[TBL] [Abstract][Full Text] [Related]
66. Use of Long-Acting Reversible Contraception (LARC) and the Depo-Provera Shot in Adolescents.
Itriyeva K
Curr Probl Pediatr Adolesc Health Care; 2018 Dec; 48(12):321-332. PubMed ID: 30466840
[TBL] [Abstract][Full Text] [Related]
67. Pediatric Practice Transformation and Long-Acting Reversible Contraception (LARC) Use in Adolescents.
Schiavoni KH; Lawrence J; Xue J; Kotelchuck M; Boudreau AA
Acad Pediatr; 2022 Mar; 22(2):296-304. PubMed ID: 34758402
[TBL] [Abstract][Full Text] [Related]
68. Cross-sectional assessment of government health center needs to implement long-acting reversible contraception services in rural Rwanda.
Mazzei A; Ingabire R; Karita E; Mukamuyango J; Nyombayire J; Parker R; Tichacek A; Allen S; Wall KM
BMC Womens Health; 2021 Dec; 21(1):411. PubMed ID: 34911535
[TBL] [Abstract][Full Text] [Related]
69. LARCs as first-line contraception - What can general practitioners advise young women?
Temple-Smith M; Sanci L
Aust Fam Physician; 2017 Oct; 46(10):710-715. PubMed ID: 29036768
[TBL] [Abstract][Full Text] [Related]
70. Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda.
Mazzei A; Ingabire R; Mukamuyango J; Nyombayire J; Sinabamenye R; Bayingana R; Parker R; Tichacek A; Easter SR; Karita E; Allen S; Wall KM
Reprod Health; 2019 Jun; 16(1):75. PubMed ID: 31164155
[TBL] [Abstract][Full Text] [Related]
71. Factors associated with the uptake of long-acting reversible contraception among female sex workers in post-conflict Northern Uganda: a cross-sectional study.
Ouma S; Tumwesigye NM; Abbo C; Ndejjo R
Reprod Health; 2022 Feb; 19(1):34. PubMed ID: 35109873
[TBL] [Abstract][Full Text] [Related]
72. Barriers and Solutions to Improve Adolescent Intrauterine Device Access.
Espey E; Yoder K; Hofler L
J Pediatr Adolesc Gynecol; 2019 Sep; 32(5S):S7-S13. PubMed ID: 31585618
[TBL] [Abstract][Full Text] [Related]
73. Self-removal of long-acting reversible contraception: A content analysis of YouTube videos.
Broussard K; Becker A
Contraception; 2021 Dec; 104(6):654-658. PubMed ID: 34400154
[TBL] [Abstract][Full Text] [Related]
74. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
[TBL] [Abstract][Full Text] [Related]
75. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
[TBL] [Abstract][Full Text] [Related]
76. Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007-2016, by term and preterm birth.
Shaw JG; Goldthwaite LM; Marić I; Shaw KA; Stevenson DK; Shaw GM
Contraception; 2023 Sep; 125():110065. PubMed ID: 37210023
[TBL] [Abstract][Full Text] [Related]
77. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial.
Mazza D; Watson CJ; Taft A; Lucke J; McGeechan K; Haas M; McNamee K; Peipert JF; Black KI
Am J Obstet Gynecol; 2020 Apr; 222(4S):S921.e1-S921.e13. PubMed ID: 31837291
[TBL] [Abstract][Full Text] [Related]
78. Development and Uptake of Long-Acting Reversible Contraception Services in Rwanda, 2009-2016.
Ingabire R; Mukamuyango J; Nyombayire J; Easter SR; Parker R; Mazzei A; Sinabamenye R; Tichacek A; Allen S; Karita E; Wall KM
J Womens Health (Larchmt); 2019 Dec; 28(12):1640-1649. PubMed ID: 31274397
[No Abstract] [Full Text] [Related]
79. 'But you can't reverse a hysterectomy!' Perceptions of long acting reversible contraception (LARC) among young women aged 16-24 years: a qualitative study.
Okpo E; Allerton L; Brechin S
Public Health; 2014 Oct; 128(10):934-9. PubMed ID: 25369357
[TBL] [Abstract][Full Text] [Related]
80. Women's Use of Long-Acting Reversible Contraception for Birth Timing and Birth Stopping.
Eeckhaut MCW; Rendall MS; Zvavitch P
Demography; 2021 Aug; 58(4):1327-1346. PubMed ID: 34251428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
